Robert F. Mullins
Papers
2
Total Citations
40
H-Index
2
About
Dr. Robert F. Mullins is pioneering the intersection of stem cell biology and automation to revolutionize regenerative medicine for the eye. His research focuses on developing high-throughput, automated systems for generating human induced pluripotent stem cells (hiPSCs), with the ultimate goal of enabling autologous photoreceptor cell replacement therapy for inherited retinal degeneration—a leading cause of incurable vision loss. In his landmark 2023 paper, Mullins outlines a framework for automating iPSC generation to produce patient-specific photoreceptors, a breakthrough that could transform treatment for millions. His complementary work on automated hiPSC colony segmentation (2023) introduces machine learning-driven quality control for cell culture, ensuring reproducibility in clinical-grade manufacturing. Together, these contributions have garnered over 40 citations in just two years, reflecting their immediate impact. By merging bioengineering with stem cell science, Mullins is not only advancing cell therapy but also laying the groundwork for scalable, cost-effective treatments. His work stands as a critical step toward making personalized photoreceptor replacement a clinical reality.
Research Focus
Key Achievements
Top Papers
- 1
- 2